U.S. Neuralgia Treatment Market Size & Outlook, 2024-2030
U.S. neuralgia treatment market, 2018-2030 (US$M)
Related Markets
U.S. neuralgia treatment market highlights
- The U.S. neuralgia treatment market generated a revenue of USD 718.9 million in 2024 and is expected to reach USD 1,018.3 million by 2030.
- The U.S. market is expected to grow at a CAGR of 6.1% from 2025 to 2030.
- In terms of segment, surgery was the largest revenue generating treatment in 2024.
- Drug Based is the most lucrative treatment segment registering the fastest growth during the forecast period.
Neuralgia treatment market data book summary
| Market revenue in 2024 | USD 718.9 million |
| Market revenue in 2030 | USD 1,018.3 million |
| Growth rate | 6.1% (CAGR from 2025 to 2030) |
| Largest segment | Surgery |
| Fastest growing segment | Drug Based |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Drug Based, Surgery |
| Key market players worldwide | GlaxoSmithKline Consumer Healthcare (GSK CH India), GlaxoSmithKline, Pfizer Inc, Novartis AG ADR, Biogen Inc, H. Lundbeck AS Class A, Cadila Pharmaceuticals |
Other key industry trends
- In terms of revenue, U.S. accounted for 30.7% of the global neuralgia treatment market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. neuralgia treatment market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 103.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Neuralgia Treatment Market Scope
Neuralgia Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. neuralgia treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neuralgia treatment market will help companies and investors design strategic landscapes.
Surgery was the largest segment with a revenue share of 68.28% in 2024. Horizon Databook has segmented the U.S. neuralgia treatment market based on drug based, surgery covering the revenue growth of each sub-segment from 2018 to 2030.
- U.S. Neuralgia Treatment Treatment Outlook (Revenue, USD Million, 2018-2030)
- Drug Based
- Anticonvulsant Medicines
- Tricyclic Antidepressants
- Surgery
- Radiofrequency Thermal Lesioning
- Stereotactic Radiosurgery
- Microvascular Decompression
- Others
- Drug Based
- U.S. Neuralgia Treatment End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospital & Clinics
- Ambulatory Surgery Centers
- Others
Reasons to subscribe to U.S. neuralgia treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. neuralgia treatment market databook
-
Our clientele includes a mix of neuralgia treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. neuralgia treatment market, including forecasts for subscribers. This country databook contains high-level insights into U.S. neuralgia treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. neuralgia treatment market size, by treatment, 2018-2030 (US$M)
U.S. Neuralgia Treatment Market Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
